Title of article :
A case of CML-like Disease with t(8;22)(q24;q11)
Author/Authors :
Yaghmaie, Marjan Hematology-Oncology and Stem Cell Transplantation Research Center - Tehran University of Medical Sciences , Valizadeh, Nasim Iran University of Medical Sciences, Tehran - Hematology-Oncology and Stem Cell Transplantation Research Center - Tehran University of Medical Sciences
Abstract :
Chronic myelogenous leukemia (CML) is characterized in 85-90% of cases by the presence of the Philadelphia (Ph) chromosome and BCR-ABL fusion gene.1 A further 5-10% of cases have other translocations, most commonly
complex variants that involve one or more chromosomal
regions in addition to bands 9q34 and 22q11, but also
simple variants that typically involve 22q11 and a
chromosome other than 9. There are a few reports
regarding observation of t(8;22) in patients with CMLlike disease.2-6
We report a case of CML-like disease with t(8;22) who
achieved hematological remission with hydroxyurea
and Imatinib. A 27-year-old Iranian male presented
with fatigue and malaise. Physical examination
revealed bilateral axillary lymphadenopathy and huge splenomegaly. Peripheral blood smear showed
hyperleukocytosis with shift to the left, basophilia, and
eosinophilia. Bone marrow aspiration and biopsy was
in accordance with CML in chronic phase. Cytogenetic
study revealed t(8; 22)(q24; q11) in all 20 metaphases
analyzed. The BCR-ABL fusion was positive which was proved to be falsely positive due to BCR gene disruption.
Keywords :
CML-like Disease , Chronic myelogenous leukemia , Philadelphia
Journal title :
Iranian Journal of Blood and Cancer (IJBC)